Whole grain rye intake, reflected by a biomarker, is associated with favorable blood lipid outcomes in subjects with the metabolic syndrome - a randomized study.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

Few studies have explored the possible plasma cholesterol lowering effects of rye consumption. The aim of this secondary analysis in the SYSDIET study was to investigate the association between plasma alkylresorcinols (AR), a biomarker for whole grain wheat and rye intake, and blood lipid concentrations in a population with metabolic syndrome. Furthermore, we analyzed the associations between the AR C17∶0/C21∶0 ratio, a suggested marker of the relative intake of whole grain/bran rye, and blood lipid concentrations.

Detaljer

Författare
  • Ola Kally Magnusdottir
  • Rikard Landberg
  • Ingibjorg Gunnarsdottir
  • Lieselotte Cloetens
  • Björn Åkesson
  • Fredrik Rosqvist
  • Ursula Schwab
  • Karl-Heinz Herzig
  • Janne Hukkanen
  • Markku J Savolainen
  • Lea Brader
  • Kjeld Hermansen
  • Marjukka Kolehmainen
  • Kaisa Poutanen
  • Matti Uusitupa
  • Ulf Risérus
  • Inga Thorsdottir
Enheter & grupper
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Biokemi och molekylärbiologi
Originalspråkengelska
Artikelnummere110827
TidskriftPLoS ONE
Volym9
Utgåva nummer10
StatusPublished - 2014
PublikationskategoriForskning
Peer review utfördJa